Omnicom buys Tokyo-based pharma research specialist
The Tokyo-based company was founded in 2007. MCI will continue to operate as a standalone agency, working closely with its sister healthcare companies within Omnicom in Asia including Targis, AgencyRx Japan and Polaris Consumer Healthcare.
Co-founder and president Takenobu Senda said: “All of us at MCI are delighted to join Omnicom’s healthcare portfolio. I am particularly looking forward to further extending our services throughout the Asia Pacific region.”
We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments